During the past decade, Institute of Hematology and Blood Transfusion conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Hematology and Blood Transfusion" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "AOP Orphan Pharmaceuticals AG" with 2 trials sponsored, "Institute of Hematology and Blood Transfusion, Czech Republic" with 2 trials sponsored, "Agios Pharmaceuticals, Inc." with 1 trials sponsored and "Ruth Tachezy, PhD." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Hematology and Blood Transfusion" #1 collaborator was "CZECRIN - Czech Clinical Research Infrastructure Network" with 1 trials as a collaborator, "Clinical Trial Center North (CTC North GmbH & Co. KG)" with 1 trials as a collaborator, "DKMS Stiftung Leben Spenden" with 1 trials as a collaborator, "Medical Healthcom Prague" with 1 trials as a collaborator and "Na Homolce Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Hematology and Blood Transfusion" are "Myelodysplastic Syndromes" (5 trials), "Leukemia" (3 trials), "Polycythemia Vera" (2 trials), "Acute Lymphoblastic Leukemia in Remission" (1 trials) and "Acute Myeloid Leukemia in Remission" (1 trials). Many other conditions were trialed in "Institute of Hematology and Blood Transfusion" in a lesser frequency.

Most popular intervention types in "Institute of Hematology and Blood Transfusion" are "Drug" (10 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "allogeneic bone marrow transplantation" (2 trials), "cytarabine" (2 trials), "etoposide" (2 trials), "idarubicin" (2 trials) and "peripheral blood stem cell transplantation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Hematology and Blood Transfusion" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Hematology and Blood Transfusion". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Institute of Hematology and Blood Transfusion, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Hematology and Blood Transfusion, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".